Tags : Johnson N Johnson Vision

Weekly Snapshot

PharmaShots Weekly Snapshot (December 02-06, 2019)

1.  Sage Therapeutics Reports Results of SAGE-217 in P-III MOUNTAIN Study for Major Depressive Disorders Published: Dec 05, 2019 | Tags: Sage Therapeutics, Reports, Results, SAGE-217, P-III, MOUNTAIN Study, Major Depressive Disorders  2. UCB Reports Results of Bimekizumab in P-III BE SURE Study for Moderate-To-Severe Chronic Plaque Psoriasis Published: Dec 06, 2019 | Tags: UCB, […]Read More


Johnson & Johnson (J&J) Vision Launches Acuvue Oasys with Transitions

Shots: J&J Vision’s Acuvue Oasys with transitions light intelligent technology is evaluated in 1000 patients results demonstrated 67% performs better in doing physical activities, 55% feel stress exposing bright & harsh light, 56% adjust light condition quickly On Apr 11, 2018 J&J Vision collaborated with Transitions Optical Limited to develop Acuvue Oasys, a lens providing […]Read More